These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 8460928

  • 1. Efficacy of ampicillin-sulbactam versus that of cefoxitin for treatment of Escherichia coli infections in a rat intra-abdominal abscess model.
    Rice LB, Carias LL, Shlaes DM.
    Antimicrob Agents Chemother; 1993 Mar; 37(3):610-2. PubMed ID: 8460928
    [Abstract] [Full Text] [Related]

  • 2. Ampicillin/sulbactam and cefoxitin in the treatment of cutaneous and other soft-tissue abscesses in patients with or without histories of injection drug abuse.
    Talan DA, Summanen PH, Finegold SM.
    Clin Infect Dis; 2000 Aug; 31(2):464-71. PubMed ID: 10987706
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of a beta-lactamase inhibitor combination for serious intraabdominal infections.
    Walker AP, Nichols RL, Wilson RF, Bivens BA, Trunkey DD, Edmiston CE, Smith JW, Condon RE.
    Ann Surg; 1993 Feb; 217(2):115-21. PubMed ID: 8439209
    [Abstract] [Full Text] [Related]

  • 4. In vitro susceptibility and in vivo efficacy of antimicrobials in the treatment of Bacteroides fragilis-Escherichia coli infection in mice.
    Brook I.
    J Infect Dis; 1989 Oct; 160(4):651-6. PubMed ID: 2677161
    [Abstract] [Full Text] [Related]

  • 5. Antibiotic penetration of experimental intra-abdominal abscesses.
    Galandiuk S, Lamos J, Montgomery W, Young S, Polk HC.
    Am Surg; 1995 Jun; 61(6):521-5. PubMed ID: 7762902
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Ampicillin-sulbactam versus cefoxitin for prophylaxis in high-risk patients undergoing abdominal surgery.
    Paladino JA, Rainstein MA, Serrianne DJ, Przylucki JE, Welage LS, Collura ML, Schentag JJ.
    Pharmacotherapy; 1994 Jun; 14(6):734-9. PubMed ID: 7885978
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of cefoxitin, cefotetan, and ampicillin/sulbactam as prophylaxis for polymicrobial infection in mice.
    Brook I.
    Clin Infect Dis; 1995 Jun; 20 Suppl 2():S376-7. PubMed ID: 7548603
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of ampicillin-sulbactam regimens simulating 1.5- and 3.0-gram doses to humans in treatment of Escherichia coli bacteremia in mice.
    Lister PD, Sanders CC.
    Antimicrob Agents Chemother; 1995 Apr; 39(4):930-6. PubMed ID: 7785998
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.